Through the looking glass: Understanding non-inferiority

Trials

Volumn 12, Issue , 2011, Pages

  Schumi, Jennifer ^a   Wittes, Janet T ^a  

^a University of Iowa   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL TRIAL; CONFIDENCE INTERVAL; ERROR; EUROPE; FOOD AND DRUG ADMINISTRATION; HUMAN; IMMUNE RESPONSE; INTENTION TO TREAT ANALYSIS; MEDICINE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PHYSICIAN; REVIEW; RISK; SENSITIVITY ANALYSIS; TUMOR VOLUME; UNITED STATES; ANIMAL; BIOASSAY; CLINICAL TRIAL (TOPIC); DEVICE APPROVAL; DRUG APPROVAL; EVIDENCE BASED MEDICINE; GOVERNMENT REGULATION; LEGAL ASPECT; METHODOLOGY; PHARMACOKINETICS; RISK ASSESSMENT; SAMPLE SIZE; TREATMENT OUTCOME;

ANIMALS; CLINICAL TRIALS AS TOPIC; DEVICE APPROVAL; DRUG APPROVAL; ENDPOINT DETERMINATION; EUROPE; EVIDENCE-BASED MEDICINE; GOVERNMENT REGULATION; HUMANS; RESEARCH DESIGN; RISK ASSESSMENT; SAMPLE SIZE; THERAPEUTIC EQUIVALENCY; TREATMENT OUTCOME; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 79955510087     PISSN: 17456215     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/1745-6215-12-106     Document Type: Review

References (18)

1. Temple R, Ellenberg SS. Placebo-controlled trials and active-control trials in the evaluation of new treatments; Part 1: Ethical and scientific issues. Annals of Internal Medicine 2000, 133:455-463.
2. Ellenberg SS, Temple R. Placebo-controlled trials and active-control trials in the evaluation of new treatments; Part 2: Practical issues and specific cases. Annals of Internal Medicine 2000, 133:464-470.
3. Wittes J. Active-control trials: a linguistic problem. International Chinese Stat Assoc Bulletin 2001, 39-40.
4. Wiens BL, Zhao W. The role of intention to treat in analysis of noninferiority studies. Clin Trials 2007, 4:286-291. 10.1177/1740774507079443, 17715258.
5. EMA Committee for Proprietary Medicinal Products (CPMP) Points to Consider on Switching between Superiority and Non-inferiority London 2000, EMA Committee for Proprietary Medicinal Products (CPMP).
6. United States Food and Drug Administration Guidance for Industry Non-Inferiority Clinical Trials 2010, United States Food and Drug Administration.
7. Rothmann M, Li N, Chen G, et al. Design and analysis of non-inferiority mortality trials in oncology. Stat Med 2003, 22:239-264.
8. Rothmann MD, Tsou HH. On non-inferiority analysis based on delta-method confidence intervals. J Biopharm Stat 2003, 13:565-583. 10.1081/BIP-120022775, 12921402.
9. EMA Committee for Medicinal Products for Human Use (CHMP) Guideline on the Choice of the Non-inferiority Margin London 2005, EMA Committee for Medicinal Products for Human Use (CHMP).
10. Snappin S, Jiang Q. Controlling the type 1 error rate in non-inferiority trials. Stat Med 2008, 27:371-381. 10.1002/sim.3072, 17914715.
11. Snappin S, Jiang Q. Preservation of effect and the regulatory approval of new treatments on the basis of non-inferiority trials. Stat Med 2008, 27:382-391. 10.1002/sim.3073, 17914712.
12. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959, 22:719-748.
13. Yusuf S, Collins R, et al. Why do we need some large, simple randomized trials?. Stat Med 1984, 3:409-420. 10.1002/sim.4780030421, 6528136.
14. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986, 7:177-188. 10.1016/0197-2456(86)90046-2, 3802833.
15. Petitti DB. Meta-analysis, Decision Analysis, and Cost-effectiveness Analysis: Methods for Quantitative Synthesis in Medicine 2000, Oxford: Oxford University Press, 306 pp.
16. Teo KK, Yusuf S, et al. Effects of intravenous magnesium in suspected acute myocardial infarction: overview of randomized trials. BMJ 1991, 303:1499-1503. 10.1136/bmj.303.6816.1499, 1671862, 1838289.
17. Fleming TR. Current issues in non-inferiority trials. Stat Med 2008, 27:317-332. 10.1002/sim.2855, 17340597.
18. Fleming TR, Powers JH. Issues in noninferiority trials: The evidence in community-acquired pneumonia. Clin Infect Dis 2008, 47(Suppl 3):S108-S120. 2673530, 18986275.